• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PCTP 通过增强致密颗粒分泌促进人血小板活化。

PCTP contributes to human platelet activation by enhancing dense granule secretion.

机构信息

Cardeza Foundation for Hematological Research, Thomas Jefferson University, Jefferson Alumni Hall, 1020 Locust Street, Philadelphia, PA 19107, USA.

Cardeza Foundation for Hematological Research, Thomas Jefferson University, Jefferson Alumni Hall, 1020 Locust Street, Philadelphia, PA 19107, USA.

出版信息

Thromb Res. 2021 Jun;202:67-73. doi: 10.1016/j.thromres.2021.03.003. Epub 2021 Mar 8.

DOI:10.1016/j.thromres.2021.03.003
PMID:33770537
Abstract

PCTP (phosphatidylcholine transfer protein) was discovered recently to regulate aggregation of human platelets stimulated with PAR4 activating peptide (PAR4AP). However, the role of PCTP following thrombin stimulation, the mechanisms by which PCTP contributes to platelet activation, and the role of PCTP with other receptors remained unknown. As mouse platelets do not express PCTP, we treated human platelets with various agonists in the presence of the specific PCTP inhibitor A1. We observed that PCTP inhibition significantly reduced dense granule secretion in response to thrombin, PAR1AP, PAR4AP, convulxin (GPVI agonist) and FcγRIIA crosslinking. In contrast, among these agonists, PCTP inhibition reduced aggregation only to low dose thrombin and PAR4AP. Unlike its effects on dense granule secretion, PCTP inhibition did not reduce alpha granule secretion in response to thrombin or PAR4AP. PCTP inhibition reduced both the increase in cytoplasmic Ca as well as PKC activity downstream of thrombin. These data are consistent with PCTP contributing to secretion of dense granules, and to being particularly important to human PAR4 early signaling events. Future studies will address further these molecular mechanisms and consequences for hemostasis and thrombosis.

摘要

PCTP(磷酸甘油酯转移蛋白)最近被发现可调节人血小板在 PAR4 激活肽(PAR4AP)刺激下的聚集。然而,在凝血酶刺激后 PCTP 的作用、PCTP 促进血小板激活的机制以及 PCTP 与其他受体的作用仍不清楚。由于小鼠血小板不表达 PCTP,我们在特定的 PCTP 抑制剂 A1 存在的情况下用各种激动剂处理人血小板。我们观察到,PCTP 抑制显著减少了对凝血酶、PAR1AP、PAR4AP、凝聚素(GPVI 激动剂)和 FcγRIIA 交联的致密颗粒分泌。相比之下,在这些激动剂中,PCTP 抑制仅减少了低剂量凝血酶和 PAR4AP 的聚集。与对致密颗粒分泌的影响不同,PCTP 抑制并没有减少对凝血酶或 PAR4AP 的α颗粒分泌。PCTP 抑制减少了凝血酶下游细胞质 Ca 的增加和 PKC 活性。这些数据表明 PCTP 有助于致密颗粒的分泌,并且对人 PAR4 的早期信号事件尤为重要。未来的研究将进一步探讨这些分子机制及其对止血和血栓形成的影响。

相似文献

1
PCTP contributes to human platelet activation by enhancing dense granule secretion.PCTP 通过增强致密颗粒分泌促进人血小板活化。
Thromb Res. 2021 Jun;202:67-73. doi: 10.1016/j.thromres.2021.03.003. Epub 2021 Mar 8.
2
Protease-activated receptor 4 activity promotes platelet granule release and platelet-leukocyte interactions.蛋白酶激活受体 4 的活性促进血小板颗粒释放和血小板-白细胞相互作用。
Platelets. 2019;30(1):126-135. doi: 10.1080/09537104.2017.1406076. Epub 2018 Dec 18.
3
The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.三磷酸腺苷(ATP)门控的P2X1受体在凝血酶和肾上腺素激活经阿司匹林处理的血小板过程中起关键作用。
J Biol Chem. 2008 Jul 4;283(27):18493-504. doi: 10.1074/jbc.M800358200. Epub 2008 May 14.
4
Lipid Receptor GPR31 (G-Protein-Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting Hemostasis.脂质受体 GPR31(G 蛋白偶联受体 31)调节血小板反应性和血栓形成而不影响止血。
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):e33-e45. doi: 10.1161/ATVBAHA.120.315154. Epub 2020 Dec 3.
5
Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c.人种间人血小板 PAR4 反应性的差异反映了 PCTP 和 miR-376c 的表达。
Nat Med. 2013 Dec;19(12):1609-16. doi: 10.1038/nm.3385. Epub 2013 Nov 10.
6
Genetic deletion of platelet PAR4 results in reduced thrombosis and impaired hemostatic plug stability.血小板 PAR4 的基因缺失可导致血栓形成减少和止血栓稳定性受损。
J Thromb Haemost. 2022 Feb;20(2):422-433. doi: 10.1111/jth.15569. Epub 2021 Nov 10.
7
Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling.蛋白酶激活受体1和4在没有分泌的ADP时不会刺激G(i)信号通路,并且独立于G(i)信号引起人血小板聚集。
Blood. 2002 May 15;99(10):3629-36. doi: 10.1182/blood.v99.10.3629.
8
Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.通过分隔的环核苷酸作用对人血小板中蛋白酶激活受体(PAR)1和PAR4信号传导的调节
J Pharmacol Exp Ther. 2007 Aug;322(2):778-88. doi: 10.1124/jpet.107.121830. Epub 2007 May 24.
9
Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets.血小板中PAR1和PAR4凝血酶受体激活及信号传导的双相动力学
Biochemistry. 2000 May 9;39(18):5458-67. doi: 10.1021/bi9927078.
10
Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca mobilization and ERK phosphorylation in healthy Japanese subjects.健康的日本受试者中,蛋白酶激活受体 4(PAR4)变体通过改变 Ca2+动员和 ERK 磷酸化来影响 PAR4 激活肽诱导的血小板反应性。
Thromb Res. 2018 Feb;162:44-52. doi: 10.1016/j.thromres.2017.12.014. Epub 2017 Dec 24.

引用本文的文献

1
Antiphospholipid antibodies in patients with stroke during COVID-19: A role in the signaling pathway leading to platelet activation.COVID-19 期间脑卒中患者的抗磷脂抗体:在导致血小板激活的信号通路中的作用。
Front Immunol. 2023 Mar 2;14:1129201. doi: 10.3389/fimmu.2023.1129201. eCollection 2023.